Fidelity Advisor Biotechnology Fund Investor Sentiment

FBTTX Fund  USD 28.80  0.01  0.03%   
Slightly above 62% of Fidelity Advisor's investor base is looking to short. The analysis of overall sentiment of trading Fidelity Advisor Biotechnology mutual fund suggests that many investors are alarmed at this time. Fidelity Advisor's investing sentiment can be driven by a variety of factors including economic data, Fidelity Advisor's earnings reports, geopolitical events, and overall market trends.
  
over six months ago at news.google.com         
BlackRock funds are crushing shareholder rights, says activist Boaz Weinstein - CNBC
Google News at Macroaxis
over a year ago at news.google.com         
White House bashes GOP plan to shift funds from Gaza aid to Israel Iron Dome Not Hamas - Fox News
Google News at Macroaxis
21 hours ago at www.macroaxis.com         
Disposition of 4961 shares by Herve Hoppenot of Incyte at 64.25 subject to Rule 16b-3
Macroaxis News
2 days ago at finance.yahoo.com         
Innovent Announces First-Time Inclusion of SINTBILO and New Indication for Olverembatinib in Chinas ...
Yahoo News
few days ago at businesswire.com         
Incyte prsentera de nouvelles donnes lors de la runion annuelle ASH 2024, y compris une prsentation ...
businesswire News
few days ago at finance.yahoo.com         
Incyte Announces Updated Presentation Time for Upcoming Investor Conference
Yahoo News
few days ago at businesswire.com         
Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicu...
businesswire News
over a week ago at insidermonkey.com         
Goldman Sachs Incyte Corporation Is A Top Growth Investor Stock
insidermonkey News
over a week ago at zacks.com         
Biotech Stock Roundup SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval More
zacks News
over a week ago at finance.yahoo.com         
Hidradenitis Suppurativa Market to Showcase Remarkable Growth at a CAGR of 12.4 percent by 2034 Delv...
Yahoo News
over a week ago at finance.yahoo.com         
Incytes 750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, ...
Yahoo News
over a week ago at smh.com.au         
ASX set to slip, global markets fall on rising Russia-Ukraine tensions
news
21 hours ago at thelincolnianonline.com         
Gilead Sciences, Inc. Insider Merdad Parsey Sells 164,211 Shares
news
2 days ago at thelincolnianonline.com         
Noesis Capital Mangement Corp Acquires 4,425 Shares of Gilead Sciences, Inc.
news
3 days ago at finance.yahoo.com         
Lead Gilead researcher highlights need for inclusive clinical trials for HIV
Yahoo News
3 days ago at gurufocus.com         
Disposition of 88119 shares by Parsey Merdad of Gilead Sciences at 65.38 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
few days ago at finance.yahoo.com         
Roche to Acquire CAR-T Cell Therapy Focused Poseida for 1.5B
Yahoo News
few days ago at benzinga.com         
Price Over Earnings Overview Gilead Sciences
benzinga news
few days ago at thelincolnianonline.com         
Hancock Whitney Corp Has 4.21 Million Holdings in Gilead Sciences, Inc.
news
few days ago at thelincolnianonline.com         
Gilead Sciences, Inc. Shares Sold by Certified Advisory Corp
news
over a week ago at finance.yahoo.com         
The Childrens Inn at NIH Announces 1 Million Grant From Gilead Sciences, Inc.
Yahoo News
over a week ago at gurufocus.com         
Gilead Sciences Announces Issuance of Senior Notes in New Indenture Agreement
Gurufocus Stories at Macroaxis
a minute ago at finance.yahoo.com         
Ionis Pharmaceuticals Down 2.8 percent Since Last Earnings Report Can It Rebound?
Yahoo News
3 days ago at finance.yahoo.com         
Ionis Pharmaceuticals Upgraded to Buy What Does It Mean for the Stock?
Yahoo News
over a week ago at finance.yahoo.com         
Why Is Ionis Pharmaceuticals, Inc. Among the Worst Performing Biotech Stocks in 2024?
Yahoo News
over a week ago at zacks.com         
LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II Study
zacks News
over a week ago at news.google.com         
Ionis Pharmaceuticals, Inc. Sees Large Increase in Short Interest - MarketBeat
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Ionis Pharmaceuticals, Inc. CEO Brett P. Monia Sells 6,630 Shares
news
over two weeks ago at investing.com         
Disposition of 13508 shares by Loscalzo Joseph of Ionis Pharmaceuticals at 37.861 subject to Rule 16...
Investing News at Macroaxis
over two weeks ago at gurufocus.com         
T. Rowe Price Investment Management, Inc. Expands Stake in Ionis Pharmaceuticals Inc
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Ionis Pharmaceuticals Reports Strong Financial Results for Q3 2024 Carlsbad, California Ionis Pharma...
news
over two weeks ago at insidermonkey.com         
Ionis Pharmaceuticals, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
21 hours ago at thelincolnianonline.com         
Caisse DE Depot ET Placement DU Quebec Sells 183,696 Shares of Vertex Pharmaceuticals Incorporated
news
2 days ago at finance.yahoo.com         
Want 1 Million in Retirement 3 Stocks to Buy Now and Hold for Decades.
Yahoo News
3 days ago at thelincolnianonline.com         
BNP Paribas Trims Stock Holdings in Vertex Pharmaceuticals Incorporated
news
few days ago at thelincolnianonline.com         
Douglass Winthrop Advisors LLC Reduces Stock Position in Vertex Pharmaceuticals Incorporated
news
few days ago at androidcentral.com         
Google adds premium tier to its Developer Program costing 299 per year
news
few days ago at kalkinemedia.com         
Long VRTX Vertex Pharmaceuticals Holds Major Support at 445 After Failed Breakout Above 500 Bullish ...
news
six days ago at businesswire.com         
PwC erffnet Google Cloud AI Experience Zones mit Lsungen auf der Basis generativer KI von Google Clo...
businesswire News
six days ago at thelincolnianonline.com         
Vertex Pharmaceuticals Incorporated Shares Purchased by Cerity Partners LLC
news
over a week ago at businesswire.com         
PwC inaugura zonas de experincia de IA da Google Cloud para apresentar solues com tecnologia de IA g...
businesswire News
over a week ago at insidermonkey.com         
Goldman Sachs Vertex Pharmaceuticals Incorporated Is A Top Growth Investor Stock
insidermonkey News
a minute ago at thelincolnianonline.com         
AbbVie Inc. Shares Sold by Janney Montgomery Scott LLC
news
a day ago at thelincolnianonline.com         
Kingfisher Capital LLC Decreases Stock Holdings in AbbVie Inc.
news
2 days ago at thelincolnianonline.com         
Financial Counselors Inc. Acquires 4,500 Shares of AbbVie Inc.
news
3 days ago at finance.yahoo.com         
Dental Soft-Tissue Regeneration Market to Hit USD 0.54 Billion by 2029 with 7.8 percent CAGR Markets...
Yahoo News
few days ago at finance.yahoo.com         
Navigating Market Uncertainty Intrinsic Value of AbbVie Inc
Yahoo News
few days ago at finance.yahoo.com         
Muscle Relaxant Drugs Market is expected to generate a revenue of USD 6.59 Billion by 2031, Globally...
Yahoo News
few days ago at finance.yahoo.com         
AbbVie to Present at Citis 2024 Global Healthcare Conference
Yahoo News
few days ago at finance.yahoo.com         
AbbVie Digital Transformation Strategy Report 2024 - Technology Focus, Technology Initiatives, ICT B...
Yahoo News
few days ago at thelincolnianonline.com         
Borer Denton Associates Inc. Has 11.52 Million Position in AbbVie Inc.
news
six days ago at thelincolnianonline.com         
Great Valley Advisor Group Inc. Buys 1,661 Shares of AbbVie Inc.
news
over a year ago at news.google.com         
FDA approves Regenerons Eylea for retinopathy of prematurity - FiercePharma
Google News at Macroaxis
21 hours ago at thelincolnianonline.com         
PFM Health Sciences LP Acquires New Position in TG Therapeutics, Inc.
news
over a week ago at kalkinemedia.com         
TG Therapeutics Stock Gains Nearly 15 percent After Recognition in Deloittes Fast 500 and Revenue Ou...
news
over a week ago at benzinga.com         
A Closer Look at TG Therapeuticss Options Market Dynamics
benzinga news
over a week ago at news.google.com         
Oppenheimer Co. Inc. Acquires New Shares in TG Therapeutics, Inc. - MarketBeat
Google News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 5000 shares by Charney Laurence N of TG Therapeutics subject to Rule 16b-3
Macroaxis News
over two weeks ago at news.google.com         
TG Therapeutics stock hits 52-week high at 28.43 - Investing.com
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
TG Therapeutics Releases Quarterly Earnings Results, Misses Expectations By 0.01 EPS
news
over three weeks ago at investing.com         
Earnings call TG Therapeutics reports robust growth for BRIUMVI
Investing News at Macroaxis
over three weeks ago at insidermonkey.com         
Disposition of 20000 shares by Echelard Yann of TG Therapeutics at 24.48 subject to Rule 16b-3
insidermonkey News
over three weeks ago at finance.yahoo.com         
TG Therapeutics Lags Q3 Earnings Estimates
Yahoo News
a minute ago at finance.yahoo.com         
Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Disease...
Yahoo News
a day ago at businesswire.com         
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
2 days ago at thelincolnianonline.com         
Qsemble Capital Management LP Makes New Investment in Sarepta Therapeutics, Inc.
news
3 days ago at investing.com         
Sarepta stock rated Overweight after Arrowhead acquisition
Investing News at Macroaxis
few days ago at investing.com         
Morgan Stanley Maintains 200 Target on Sarepta Shares
Investing News at Macroaxis
few days ago at investors.com         
Arrowhead Launches 25 percent On A Massive Licensing Deal With Sarepta
Investors Business Daily at Macroaxis
few days ago at www.macroaxis.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Macroaxis News
over a week ago at thelincolnianonline.com         
Connor Clark Lunn Investment Management Ltd. Acquires 18,095 Shares of Sarepta Therapeutics, Inc.
news
over a week ago at investing.com         
Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
Yahoo News
over six months ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over six months ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over six months ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over six months ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over six months ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over six months ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over six months ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over six months ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over six months ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over six months ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
a day ago at thelincolnianonline.com         
Vinva Investment Management Ltd Sells 1,055 Shares of Regeneron Pharmaceuticals, Inc.
news
3 days ago at gurufocus.com         
Regeneron Pharmaceuticals Inc Faces Legal Scrutiny Over Alleged Medicare Fraud
Gurufocus Stories at Macroaxis
3 days ago at finance.yahoo.com         
Lung Cancer Therapeutics Market Analysis by treatment into Chemotherapy, Targeted Therapy, Radiother...
Yahoo News
few days ago at businesswire.com         
INVESTOR ALERT Law Offices of Howard G. Smith Continues Investigation of Regeneron Pharmaceuticals, ...
businesswire News
few days ago at finance.yahoo.com         
Neuroendocrine Tumors Market to Showcase Rapid Growth During the Study Period , at a CAGR of 5.1 Del...
Yahoo News
few days ago at thelincolnianonline.com         
Bedell Frazier Investment Counselling LLC Has 5.06 Million Stock Position in Regeneron Pharmaceutica...
news
over a week ago at simplywall.st         
Regeneron Pharmaceuticals, Inc.s Price Is Out Of Tune With Earnings
Simply Wall St News at Macroaxis
over a week ago at businesswire.com         
BioFuture 2024 Wraps Up Hundreds of High-Profile Attendees Joined Record Numbers of Investors and Me...
businesswire News
over a week ago at finance.yahoo.com         
BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA through Ga...
Yahoo News
over a week ago at thelincolnianonline.com         
HealthInvest Partners AB Has 7. Million Stake in Regeneron Pharmaceuticals, Inc.
news
a day ago at thelincolnianonline.com         
Protagonist Therapeutics, Inc. Insider Arturo Md Molina Sells 26,000 Shares
news
2 days ago at investing.com         
Protagonist Therapeutics chief development officer sells 5.6 million in stock
Investing News at Macroaxis
few days ago at www.macroaxis.com         
Disposition of 21480 shares by Dinesh Patel of Protagonist Therapeutics at 46.25 subject to Rule 16b...
Macroaxis News
six days ago at news.google.com         
Victory Capital Management Inc. Has 5.89 Million Stake in Protagonist Therapeutics, Inc. - MarketBea...
Google News at Macroaxis
over a week ago at thelincolnianonline.com         
Protagonist Therapeutics Shares Gap Down on Insider Selling
news
over a week ago at finance.yahoo.com         
JJ pill clears skin in two late-stage psoriasis studies
Yahoo News
over two weeks ago at thelincolnianonline.com         
Protagonist Therapeutics, Inc. Shares Sold by King Wealth Management Group
news
over two weeks ago at zacks.com         
Protagonist Therapeutics Upgraded to Buy Heres What You Should Know
zacks News
over three weeks ago at finance.yahoo.com         
Protagonist Therapeutics Q3 Earnings Snapshot
Yahoo News
over three weeks ago at thelincolnianonline.com         
Wedbush Reiterates Outperform Rating for Protagonist Therapeutics
news
a day ago at zacks.com         
Novavax, Inc. Is a Trending Stock Facts to Know Before Betting on It
zacks News
3 days ago at cnet.com         
These Are the Vaccines You Need if Youre 50 or Up
Macroaxis News: cnet.com
over a week ago at marketbeat.com         
Is Biotechs Bull Run Over Examining Election Impacts
Marketbeat News
over a week ago at finance.yahoo.com         
Investors Heavily Search Novavax, Inc. Here is What You Need to Know
Yahoo News
over two weeks ago at accesswire.com         
Novavax, Inc. Shareholders May Have Been Affected by Fraud - Levi Korsinsky Investigates
news
over two weeks ago at bnnbloomberg.ca         
RFK Jr.s Leadership Seen Accelerating Faltering Vaccine Use
bloomberg News
over two weeks ago at nypost.com         
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department
news
over two weeks ago at finance.yahoo.com         
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635
Yahoo News
over two weeks ago at simplywall.st         
Novavax, Inc. Just Reported, And Analysts Assigned A US16.67 Price Target
Simply Wall St News at Macroaxis
over two weeks ago at cnn.com         
Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary
CNN News
a minute ago at finance.yahoo.com         
Neurocrines Phase II schizophrenia trial fails to meet primary endpoint
Yahoo News
2 days ago at thelincolnianonline.com         
Truvestments Capital LLC Takes 63,000 Position in Neurocrine Biosciences, Inc.
news
six days ago at thelincolnianonline.com         
Landscape Capital Management L.L.C. Invests 1 Million in Neurocrine Biosciences, Inc.
news
over a week ago at businesswire.com         
Helpr Employer-Subsidized Family Care App with Patented My Choice Technology Expands Service to 150 ...
businesswire News
over a week ago at thelincolnianonline.com         
Neurocrine Biosciences, Inc. Shares Bought by Impax Asset Management Group plc
news
over two weeks ago at investing.com         
Spruce Biosciences SWOT analysis tildacerfonts fate hangs on Q4 trial results
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
Voyager Reports Third Quarter 2024 Financial and Operating Results
Yahoo News
over two weeks ago at finance.yahoo.com         
Disposition of 5140 shares by Roberts Eiry of Neurocrine Biosciences at 77.81 subject to Rule 16b-3
Yahoo News
over three weeks ago at finance.yahoo.com         
Neurocrine Biosciences Presents New Data on INGREZZA Capsules at Psych Congress 2024 Majority of Lon...
Yahoo News
over three weeks ago at thelincolnianonline.com         
Neurocrine Biosciences Issues Quarterly Earnings Results, Misses Expectations By 0.23 EPS
news
over a year ago at news.google.com         
Rain Oncology Multiple Data Catalysts In 2023 For This Precision ... - Seeking Alpha
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Antibody Drug Conjugates Global Market Report 2023
Yahoo News
a day ago at zacks.com         
Heres Why Exelixis is a Strong Momentum Stock
zacks News
3 days ago at investing.com         
Exelixis EVP Haley Patrick J. sells 352,700 in stock
Investing News at Macroaxis
3 days ago at finance.yahoo.com         
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in December
Yahoo News
few days ago at businesswire.com         
Exelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib fo...
businesswire News
few days ago at globenewswire.com         
EXEL Industries Guillaume Jacq appointed Chief Financial Officer of the EXEL Industries Group
Macroaxis News: globenewswire.com
over a week ago at www.macroaxis.com         
Disposition of 10000 shares by Haley Patrick J. of Exelixis at 35.27 subject to Rule 16b-3
Macroaxis News
over a week ago at thelincolnianonline.com         
Ontario Teachers Pension Plan Board Has 930,000 Stock Holdings in Exelixis, Inc.
news
over a week ago at finance.yahoo.com         
EXEL vs. CSLLY Which Stock Is the Better Value Option?
Yahoo News
over a week ago at zacks.com         
Merck Stock Trades Near 52-Week Low Whats Next for Investors?
zacks News
over a week ago at finance.yahoo.com         
Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity
Yahoo News
few days ago at finance.yahoo.com         
Is Agios Pharmaceuticals Stock Outpacing Its Medical Peers This Year?
Yahoo News
over a week ago at news.google.com         
Brokerages Set Agios Pharmaceuticals, Inc. Price Target at 52.33 - MarketBeat
Google News at Macroaxis
over two weeks ago at investing.com         
Agios Pharmaceuticals chief legal officer sells 1.14 million in stock
Investing News at Macroaxis
over two weeks ago at www.macroaxis.com         
Disposition of 1500 shares by Ballal Rahul D. of Agios Pharm at 59.21 subject to Rule 16b-3
Macroaxis News
over three weeks ago at finance.yahoo.com         
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meet...
Yahoo News
over three weeks ago at finance.yahoo.com         
Agios Pharmaceuticals Third Quarter 2024 Earnings EPS Beats Expectations, Revenues Lag
Yahoo News
over three weeks ago at finance.yahoo.com         
Is ADC Therapeutics Stock Outpacing Its Medical Peers This Year?
Yahoo News
over three weeks ago at seekingalpha.com         
Agios Pharmaceuticals GAAP EPS of 16.22 beats by 7.53, revenue of 8.96M misses by 0.54M
seekingalpha News
over a month ago at seekingalpha.com         
Agios Pharmaceuticals Q3 2024 Earnings Preview
seekingalpha News
over a month ago at finance.yahoo.com         
Thermo Fishers Oncomine gains FDA approval as brain tumor diagnostic
Yahoo News
a day ago at finance.yahoo.com         
High Growth Tech Stocks To Watch For Promising Portfolio Growth
Yahoo News
3 days ago at investing.com         
Alnylam Pharmaceuticals CSO sells 754,945 in stock
Investing News at Macroaxis
3 days ago at investing.com         
Disposition of 110 shares by Kevin Fitzgerald of Alnylam Pharmaceuticals at 254.48 subject to Rule 1...
Investing News at Macroaxis
few days ago at finance.yahoo.com         
Exploring Three High Growth Tech Stocks With Promising Potential
Yahoo News
few days ago at statnews.com         
What to make of Trumps health care nominees
news
over a week ago at finance.yahoo.com         
BridgeBio heart drug approved by FDA, setting up battle with Pfizer
Yahoo News
over a week ago at bnnbloomberg.ca         
Jefferies Taps Former Alnylam CEO Maraganore as Senior Adviser
bloomberg News
over a week ago at thelincolnianonline.com         
TrinityPoint Wealth LLC Makes New 200,000 Investment in Alnylam Pharmaceuticals, Inc.
news
over a week ago at finance.yahoo.com         
High Growth Tech And Two Other Promising Stocks with Potential for Expansion
Yahoo News
over a week ago at businesswire.com         
Alnylam Announces Interim Phase 1 Data of Nucresiran Showing Rapid Knockdown of TTR that is Sustaine...
businesswire News
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
a minute ago at zacks.com         
Amgen Inc. Is a Trending Stock Facts to Know Before Betting on It
zacks News
a day ago at gurufocus.com         
Amgen Inc to Present at 7th Annual Evercore HealthCONx Conference
Gurufocus Stories at Macroaxis
2 days ago at finance.yahoo.com         
TEVA Stock Down 10 percent in a Month Should You Buy the Dip?
Yahoo News
3 days ago at newsweek.com         
Amgen drug delivers more weight loss than competitors
news
few days ago at investing.com         
Amgen shares hold as Oppenheimer keeps 380 target
Investing News at Macroaxis
few days ago at medcitynews.com         
Weight Loss With Amgen Drug in Line With Eli Lilly Med, But Dosing Could Be Differentiator
news
six days ago at thelincolnianonline.com         
Pitcairn Co. Trims Stock Position in Amgen Inc.
news
over a week ago at zacks.com         
Novo Nordisk Plunges 25 percent in 3 Months How to Play the Stock
zacks News
over a week ago at finance.yahoo.com         
Palisade Bio to Present Preclinical Results for PALI-2108 Demonstrating Engagement of Key Fibrotic P...
Yahoo News
over a week ago at benzinga.com         
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
benzinga news
3 days ago at thelincolnianonline.com         
Cynosure Group LLC Sells 499 Shares of argenx SE
news
over a week ago at investing.com         
Can Argenx stock sustain its autoimmune category dominance Oppenheimer weighs in
Investing News at Macroaxis
over a week ago at finance.yahoo.com         
Is argenx SE the Best Immunotherapy Stock to Buy Now?
Yahoo News
over two weeks ago at gurufocus.com         
Paradigm Biocapital Advisors LP Increases Stake in Tarsus Pharmaceuticals Inc
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Deep Track Capital, LP Acquires New Stake in Silence Therapeutics PLC
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Artisan Partners Limited Partnership Bolsters Stake in iRhythm Technologies Inc
Gurufocus Stories at Macroaxis
over three weeks ago at zacks.com         
Is Argenx Outperforming Other Medical Stocks This Year?
zacks News
over three weeks ago at thelincolnianonline.com         
argenx SE Stake Lowered by AlphaCentric Advisors LLC
news
over three weeks ago at thelincolnianonline.com         
argenx Issues Earnings Results
news
over three weeks ago at finance.yahoo.com         
Heres Why You Should Hold Argenx SE
Yahoo News
2 days ago at finance.yahoo.com         
Health Canada approves Novo Nordisks Wegovy to cut heart attacks
Yahoo News
over a week ago at news.google.com         
Ascendis Pharmas SWOT analysis stock faces growth hurdles amid pipeline promise - Investing.com Indi...
Google News at Macroaxis
over a week ago at simplywall.st         
Ascendis Pharma Third Quarter 2024 Earnings Misses Expectations
Simply Wall St News at Macroaxis
over two weeks ago at investing.com         
Citi cuts Ascendis Pharma stock target, maintains buy rating on volume growth
Investing News at Macroaxis
over two weeks ago at insidermonkey.com         
Ascendis Pharma AS Q3 2024 Earnings Call Transcript
insidermonkey News
over two weeks ago at thelincolnianonline.com         
Sivik Global Healthcare LLC Buys Shares of 10,000 Ascendis Pharma AS
news
over two weeks ago at seekingalpha.com         
Ascendis Pharma GAAP EPS of -1.72, revenue of 57.83M
seekingalpha News
over two weeks ago at seekingalpha.com         
Ascendis Pharma Q3 2024 Earnings Preview
seekingalpha News
over three weeks ago at finance.yahoo.com         
Heres Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical
Yahoo News
over three weeks ago at benzinga.com         
Novo Nordisk Q3 Preview Will 285 Million Weight Loss Bet Offset Bearish Charts?
benzinga news
2 days ago at thelincolnianonline.com         
Dynamic Technology Lab Private Ltd Purchases Shares of 14,376 BioMarin Pharmaceutical Inc.
news
3 days ago at insidermonkey.com         
Why Is BioMarin Pharmaceutical Inc. Among the Worst Performing Healthcare Stocks in 2024?
insidermonkey News
over a week ago at marketbeat.com         
Can BioMarin Stock Live Up to Wall Streets High Expectations?
Marketbeat News
over a week ago at finance.yahoo.com         
Why Is BioMarin Pharmaceutical Inc. Among the Worst Performing Biotech Stocks in 2024?
Yahoo News
over a week ago at insidermonkey.com         
BioMarin Pharmaceutical Inc. Among the Best Genomics Stocks to Buy Right Now
insidermonkey News
over two weeks ago at investing.com         
Biomarin pharmaceuticals CTO sells 350k in stock
Investing News at Macroaxis
over two weeks ago at investing.com         
Sangamo Therapeutics SWOT analysis gene therapy firms stock faces challenges, opportunities
Investing News at Macroaxis
over two weeks ago at bnnbloomberg.ca         
Elliott Partner Bhanji Is Leaving Firm After More Than a Decade
bloomberg News
over three weeks ago at insidermonkey.com         
Heres Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical
insidermonkey News
over three weeks ago at businesswire.com         
RIBOMIC Announces Positive Interim Results from Phase IIa Trial of umedaptanib pegol in Achondroplas...
businesswire News
a minute ago at fortune.com         
Hawaii court orders Bristol Myers Squibb and Sanofi to pay the state 916m in Plavix blood thinner la...
news
a day ago at independent.co.uk         
Joe Marler insists retirement timing right after Harlequins crushed by Bristol
news
2 days ago at bbc.co.uk         
M49 Person taken to hospital after four-vehicle crash near Bristol
news
3 days ago at cnbc.com         
2 things we always learn about a company before we decide whether to buy its stock
cnbc News
few days ago at finance.yahoo.com         
Polycystic Ovary Syndrome Treatment Market to Reach 6.84 Billion by 2034 with 4.7 percent CAGR Fact....
Yahoo News
few days ago at independent.co.uk         
Watford vs Bristol City LIVE Championship team news, line-ups and more
news
few days ago at thelincolnianonline.com         
Hancock Whitney Corp Buys 294,717 Shares of Bristol-Myers Squibb
news
few days ago at patch.com         
6 More Victims Were Drugged, Raped By Bristol Twp Man Bucks DA
patch News
few days ago at thelincolnianonline.com         
Bristol-Myers Squibb Shares Acquired by SevenBridge Financial Group LLC
news
few days ago at bbc.co.uk         
Bristol Bears 40-15 Ampthill Bears run in six tries in Premiership Rugby Cup
news
a day ago at finance.yahoo.com         
Blueprint Medicines Up 8.7 percent Since Last Earnings Report Can It Continue?
Yahoo News
few days ago at simplywall.st         
Is Blueprint Medicines Using Debt In A Risky Way?
Simply Wall St News at Macroaxis
over a week ago at news.google.com         
Disposition of 7500 shares by Coats Lonnel of Blueprint Medicines at 69.79 subject to Rule 16b-3
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
HC Wainwright Reaffirms Buy Rating for Blueprint Medicines
news
over two weeks ago at gurufocus.com         
Rock Springs Capital Management LP Acquires Significant Stake in Mereo BioPharma Group PLC
Gurufocus Stories at Macroaxis
over three weeks ago at finance.yahoo.com         
Disposition of 5000 shares by Albers Jeffrey W. of Blueprint Medicines at 36.05 subject to Rule 16b-...
Yahoo News
over three weeks ago at simplywall.st         
Blueprint Medicines Third Quarter 2024 Earnings EPS Beats Expectations
Simply Wall St News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Blueprint Medicines Announces Earnings Results, Beats Estimates By 0.08 EPS
news
over three weeks ago at thelincolnianonline.com         
Blueprint Medicines Given New 151.00 Price Target at Wells Fargo Company
news
over three weeks ago at insidermonkey.com         
Blueprint Medicines Corporation Q3 2024 Earnings Call Transcript
insidermonkey News
2 days ago at thelincolnianonline.com         
Insider Selling Cytokinetics, Incorporated EVP Sells 7,300 Shares of Stock
news
few days ago at www.macroaxis.com         
Disposition of 5300 shares by Malik Fady Ibraham of Cytokinetics at 7.96 subject to Rule 16b-3
Macroaxis News
few days ago at thelincolnianonline.com         
Analysts Weekly Ratings Changes for Cytokinetics
news
over a week ago at insidermonkey.com         
Why Is Cytokinetics, Incorporated Among the Worst Performing Biotech Stocks in 2024?
insidermonkey News
over a week ago at investing.com         
Goldman Sachs maintains Neutral on Cytokinetics, 60 target
Investing News at Macroaxis
over a week ago at investing.com         
Disposition of 5000 shares by Robert Blum of Cytokinetics at 6.67 subject to Rule 16b-3
Investing News at Macroaxis
over a week ago at globenewswire.com         
Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific ...
Macroaxis News: globenewswire.com
over two weeks ago at gurufocus.com         
Significant Portfolio Addition T. Rowe Price Investment Management, Inc. ...
Gurufocus Stories at Macroaxis
over two weeks ago at investing.com         
Cytokinetics EVP sells 370,880 in stock
Investing News at Macroaxis
over two weeks ago at seekingalpha.com         
Cytokinetics reports initiation of phase 1 clinical study of CK-4015089
seekingalpha News
over a week ago at finance.yahoo.com         
Bluejay Therapeutics Announces Expansion of Leadership Team andBoard of Directors
Yahoo News
over two weeks ago at finance.yahoo.com         
FibroGen Third Quarter 2024 Earnings Beats Expectations
Yahoo News
over two weeks ago at investing.com         
Earnings call FibroGen reports strong Q3 sales, advances in oncology pipeline
Investing News at Macroaxis
over two weeks ago at seekingalpha.com         
FibroGen GAAP EPS of -0.17 beats by 0.06, revenue of 46.3M beats by 11.54M
seekingalpha News
over two weeks ago at zacks.com         
FibroGen Reports Q3 Loss, Tops Revenue Estimates
zacks News
over three weeks ago at globenewswire.com         
FibroGen to Report Third Quarter 2024 Financial Results
Macroaxis News: globenewswire.com
over a month ago at finance.yahoo.com         
Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer
Yahoo News
over a month ago at simplywall.st         
FibroGens US6.2m Market Cap Fall Books Insider Losses
Simply Wall St News at Macroaxis
over two months ago at thelincolnianonline.com         
Short Interest in FibroGen, Inc. Decreases By 7.1
news
over two months ago at seekingalpha.com         
FibroGen CFO, CMO to leave company by years end
seekingalpha News
over a year ago at news.google.com         
Netupitant Palonosetron FDC Market Size is Expected to Exhibit US 532228.43 million by 2028 Eisai Ph...
Google News at Macroaxis
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at finance.yahoo.com         
Leqembi launched in South Korea
Yahoo News
2 days ago at gurufocus.com         
Biogen Inc and Eisai Launch Alzheimers Treatment LEQEMBI in South Korea
Gurufocus Stories at Macroaxis
3 days ago at insidermonkey.com         
Why Is Biogen Inc. Among the Worst Performing Healthcare Stocks in 2024?
insidermonkey News
few days ago at benzinga.com         
Smart Money Is Betting Big In BIIB Options
benzinga news
over a week ago at finance.yahoo.com         
Goldman Sachs Biogen Inc. Is A Top Growth Investor Stock
Yahoo News
over a week ago at investing.com         
Sage shares target cut, maintains hold on failed drug study
Investing News at Macroaxis
over a week ago at benzinga.com         
Biogen Unusual Options Activity For November 20
benzinga news
over a week ago at finance.yahoo.com         
Immunomodulators Market to hit USD 388.7 billion by 2032, says Global Market Insights Inc.
Yahoo News
over a week ago at finance.yahoo.com         
How decentralisation can fill the gaps in Alzheimers research
Yahoo News
a day ago at prnewswire.com         
BLUE LOCK CEMENTS ITSELF AS AN INTERNATIONAL HIT AS EPISODE NAGI EARNS 23.3 MILLION AT THE GLOBAL BO...
prnewswire News
few days ago at prnewswire.com         
WYNNEFIELD GROUP SENDS DEFINITIVE PROXY MATERIALS TO TECHPRECISION STOCKHOLDERS, INCLUDING A BLUE PR...
prnewswire News
over a week ago at finance.yahoo.com         
Isle Blue Redefines Luxury Travel with Exclusive Miami Villa Collection
Yahoo News
over two weeks ago at gurufocus.com         
bluebird bio Inc Q3 2024 Earnings Call Highlights Navigating Revenue Challenges and ...
Gurufocus Stories at Macroaxis
over two weeks ago at investing.com         
Bluebird bio stock downgraded, price target slashed on financial update
Investing News at Macroaxis
over two weeks ago at bizjournals.com         
Bluebird bio says it needs cash to operate beyond March 2025
bizjournals News
over two weeks ago at gurufocus.com         
Goldman Sachs Group Incs Strategic Acquisition of Shares in bluebird bio Inc
Gurufocus Stories at Macroaxis
over two weeks ago at newswire.com         
Fusion Energy Agreement Between RSE and BLUE LASER FUSION
news
over two weeks ago at finance.yahoo.com         
Acquisition by Leschly Nick of 49850 shares of Bluebird Bio at 0.44 subject to Rule 16b-3
Yahoo News
over three weeks ago at gurufocus.com         
Vanguard Group Incs Strategic Acquisition of Shares in bluebird bio Inc
Gurufocus Stories at Macroaxis
21 hours ago at thelincolnianonline.com         
Sage Therapeutics, Inc. Receives 12.83 Average PT from Analysts
news
few days ago at finance.yahoo.com         
A Brand New Bathhouse is Open in Renton
Yahoo News
over a week ago at seekingalpha.com         
Sage raised to sector perform by RBC in wake of drug failure
seekingalpha News
over a week ago at businesswire.com         
Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor in the T...
businesswire News
over a week ago at bizjournals.com         
Third trial failure is end-of-the-road for Sages neurological drug
bizjournals News
over two weeks ago at accesswire.com         
SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japans Patent Office Protect...
news
over three weeks ago at finance.yahoo.com         
Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer Head of Quality
Yahoo News
over three weeks ago at thelincolnianonline.com         
Sage Therapeutics Price Target Cut to 8.00 by Analysts at Oppenheimer
news
over three weeks ago at bizjournals.com         
Cambridge biotechs layoffs will cut dozens of Mass. employees
bizjournals News
over three weeks ago at globenewswire.com         
Sage and Artis Trade Join Forces to Accelerate Document Automation and Drive Efficiency in Secured F...
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Fidelity Advisor that are available to investors today. That information is available publicly through Fidelity media outlets and privately through word of mouth or via Fidelity internal channels. However, regardless of the origin, that massive amount of Fidelity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fidelity Advisor news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fidelity Advisor relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fidelity Advisor's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fidelity Advisor alpha.

Other Information on Investing in Fidelity Mutual Fund

Fidelity Advisor financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Advisor security.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation